Picture of Recursion Pharmaceuticals logo

RXRX — Recursion Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Recursion to Host Webinar on Tupelo Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis on Dec. 8

Dec 1 (Reuters) - Recursion Pharmaceuticals Inc RXRX.O:

RECURSION ANNOUNCES WEBINAR FOR UPCOMING CLINICAL DATA READOUT ON THE TUPELO PHASE 1B/2 TRIAL OF REC-4881 IN FAMILIAL ADENOMATOUS POLYPOSIS ON DECEMBER 8, 2025

Source text: ID:nGNX15GLWS

Further company coverage: RXRX.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Recursion Pharmaceuticals

See all news